• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外研究一种由细菌纤维素制成的无支架主动脉生物瓣。

In Vitro Study of a Stentless Aortic Bioprosthesis Made of Bacterial Cellulose.

机构信息

Medical Engineering Division, Maritime Advanced Research Centre, Szczecińska 65, 80-392, Gdańsk, Poland.

Cardiac and Vascular Surgery Department, Medical University of Gdańsk, Dębinki 7, 80-211, Gdańsk, Poland.

出版信息

Cardiovasc Eng Technol. 2020 Dec;11(6):646-654. doi: 10.1007/s13239-020-00500-z. Epub 2020 Nov 17.

DOI:10.1007/s13239-020-00500-z
PMID:33205361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7782396/
Abstract

PURPOSE

The paper present findings from an in vitro experimental study of a stentless human aortic bioprosthesis (HAB) made of bacterial cellulose (BC). Three variants of the basic model were designed and tested to identify the valve prosthesis with the best performance parameters. The modified models were made of BC, and the basic model of pericardium.

METHODS

Each model (named V, V and V) was implanted into a 90 mm porcine aorta. Effective Orifice Area (EOA), rapid valve opening time (RVOT) and rapid valve closing time (RVCT) were determined. The flow resistance of each bioprosthesis model during the simulated heart systole, i.e. for the mean differential pressure (ΔP) at the time of full valve opening was measured. All experimental specimens were exposed to a mean blood pressure (MBP) of 90.5 ± 2.3 mmHg.

RESULTS

The V model demonstrated the best performance. The index defining the maximum opening of the bioprosthesis during systole for models V, V and V was 2.67 ± 0.59, 2.04 ± 0.23 and 2.85 ± 0.59 cm, respectively. The mean flow rate through the V valve was 5.7 ± 1, 6.9 ± 0.7 and 8.9 ± 1.4 l/min for stroke volume (SV) of 65, 90 and 110 mL, respectively. The phase of immediate opening and closure for models V, V and V was 8, 7 and 5% of the cycle duration, respectively. The mean flow resistance of the models was: 4.07 ± 2.1, 4.28 ± 2.51 and 5.6 ± 2.32 mmHg.

CONCLUSIONS

The V model of the aortic valve prosthesis is the most effective. In vivo tests using BC as a structural material for this model are recommended. The response time of the V model to changed work conditions is comparable to that of a healthy human heart. The model functions as an aortic valve prosthesis in in vitro conditions.

摘要

目的

本文介绍了一种由细菌纤维素(BC)制成的无支架人工主动脉生物瓣(HAB)的体外实验研究结果。设计并测试了三种基本模型的变体,以确定性能参数最佳的瓣膜假体。改良模型由 BC 和心包制成,基本模型由心包制成。

方法

将每个模型(分别命名为 V、V 和 V)植入 90mm 猪主动脉。确定有效瓣口面积(EOA)、快速瓣膜开启时间(RVOT)和快速瓣膜关闭时间(RVCT)。测量每个生物假体模型在模拟心脏收缩期间的流动阻力,即在瓣膜完全打开时的平均压差(ΔP)。所有实验标本均暴露于平均血压(MBP)90.5±2.3mmHg。

结果

V 型模型表现最佳。模型 V、V 和 V 的最大瓣膜开启指数定义为 2.67±0.59、2.04±0.23 和 2.85±0.59cm。V 型瓣膜的平均流量为 5.7±1、6.9±0.7 和 8.9±1.4l/min,对于 65、90 和 110ml 的每搏量(SV)。模型 V、V 和 V 的立即开启和关闭相位分别为周期持续时间的 8%、7%和 5%。模型的平均流动阻力分别为:4.07±2.1、4.28±2.51 和 5.6±2.32mmHg。

结论

V 型主动脉瓣假体最有效。建议使用 BC 作为该模型的结构材料进行体内测试。V 型模型对工作条件变化的响应时间与健康人心脏相当。该模型在体外条件下作为主动脉瓣假体起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/9e7a38f9cb61/13239_2020_500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/1c6469f4e800/13239_2020_500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/967018d113c4/13239_2020_500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/f98e5af28ae9/13239_2020_500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/9e7a38f9cb61/13239_2020_500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/1c6469f4e800/13239_2020_500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/967018d113c4/13239_2020_500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/f98e5af28ae9/13239_2020_500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/732a/7782396/9e7a38f9cb61/13239_2020_500_Fig4_HTML.jpg

相似文献

1
In Vitro Study of a Stentless Aortic Bioprosthesis Made of Bacterial Cellulose.体外研究一种由细菌纤维素制成的无支架主动脉生物瓣。
Cardiovasc Eng Technol. 2020 Dec;11(6):646-654. doi: 10.1007/s13239-020-00500-z. Epub 2020 Nov 17.
2
Opening-closing pattern of four pericardial prostheses: results from an in vitro study of leaflet kinematics.四种心包瓣膜假体的开闭模式:瓣叶运动学的体外研究结果
J Artif Organs. 2016 Dec;19(4):350-356. doi: 10.1007/s10047-016-0910-0. Epub 2016 May 26.
3
[Hemodynamic performance of newly developed composite stentless porcine aortic valve: in vitro testing and in vivo experiment with sheep].[新开发的复合无支架猪主动脉瓣膜的血流动力学性能:体外测试及绵羊体内实验]
Zhonghua Yi Xue Za Zhi. 2008 Jul 29;88(29):2059-63.
4
The Toronto root stentless valve in the subcoronary position is hemodynamically superior to the mosaic stented completely supra-annular bioprosthesis.置于冠状动脉下位置的多伦多无支架瓣膜在血流动力学上优于镶嵌式带支架完全瓣环上生物假体。
J Heart Valve Dis. 2005 Nov;14(6):814-21; discussion 821.
5
Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review.生物主动脉瓣置换术:与带支架瓣膜替代品相比,无支架瓣膜的优势及最佳适应证。综述
Gen Thorac Cardiovasc Surg. 2018 May;66(5):247-256. doi: 10.1007/s11748-018-0884-3. Epub 2018 Jan 10.
6
How Can We Help a Patient With a Small Failing Bioprosthesis?: An In Vitro Case Study.如何帮助一位小型生物假体功能不良的患者?一项体外案例研究。
JACC Cardiovasc Interv. 2015 Dec 28;8(15):2026-2033. doi: 10.1016/j.jcin.2015.08.028. Epub 2015 Nov 27.
7
Hemodynamic performance of mitroflow aortic pericardial bioprosthesis - optimizing management for the small aortic annulus.米特罗流主动脉心包生物假体的血流动力学性能——优化小主动脉瓣环的管理
Thorac Cardiovasc Surg. 2010 Mar;58(2):69-75. doi: 10.1055/s-0029-1240626. Epub 2010 Mar 23.
8
Melody valve implantation within freestyle stentless porcine aortic heterograft.在自由式无支架猪主动脉异种移植中植入旋律瓣膜。
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1224-1230. doi: 10.1002/ccd.26862. Epub 2016 Nov 26.
9
Preassembled stentless valved-conduit for the replacement of the ascending aorta and aortic root.用于升主动脉和主动脉根部置换的预组装无支架带瓣管道。
Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):964-8. doi: 10.1510/icvts.2008.184457. Epub 2008 Aug 19.
10
Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results.新一代无支架心包瓣膜置换主动脉瓣:短期临床和血流动力学结果。
J Heart Valve Dis. 2005 Sep;14(5):623-9.

引用本文的文献

1
Highly Aligned Bacterial Nanocellulose Films Obtained During Static Biosynthesis in a Reproducible and Straightforward Approach.在可重复且直接的静态生物合成过程中获得高度有序的细菌纳米纤维素薄膜。
Adv Sci (Weinh). 2022 Sep;9(26):e2201947. doi: 10.1002/advs.202201947. Epub 2022 Jul 21.
2
Bacterial Cellulose Properties Fulfilling Requirements for a Biomaterial of Choice in Reconstructive Surgery and Wound Healing.细菌纤维素的特性满足了整形外科和伤口愈合中首选生物材料的要求。
Front Bioeng Biotechnol. 2022 Feb 11;9:805053. doi: 10.3389/fbioe.2021.805053. eCollection 2021.

本文引用的文献

1
Assessment of the usefulness of bacterial cellulose produced by Gluconacetobacter xylinus E as a new biological implant.评估木醋杆菌产生的细菌纤维素作为新型生物植入物的有用性。
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:302-312. doi: 10.1016/j.msec.2018.12.016. Epub 2018 Dec 14.
2
Long-term outcomes using the stentless LivaNova-Sorin Pericarbon Freedom™ valve after aortic valve replacement.
Interact Cardiovasc Thorac Surg. 2018 Jul 1;27(1):116-123. doi: 10.1093/icvts/ivy012.
3
Physiological vortices in the sinuses of Valsalva: An in vitro approach for bio-prosthetic valves.主动脉瓣窦内的生理涡流:生物人工瓣膜的体外研究方法。
J Biomech. 2016 Sep 6;49(13):2635-2643. doi: 10.1016/j.jbiomech.2016.05.027. Epub 2016 Jun 1.
4
Applications of bacterial cellulose and its composites in biomedicine.细菌纤维素及其复合材料在生物医学中的应用。
Appl Microbiol Biotechnol. 2015 Mar;99(6):2491-511. doi: 10.1007/s00253-015-6426-3. Epub 2015 Feb 11.
5
Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.804例接受Freedom SOLO无支架主动脉瓣膜患者的临床和血流动力学结果:一项国际前瞻性多中心研究的结果
Eur J Cardiothorac Surg. 2015 Mar;47(3):e97-104. doi: 10.1093/ejcts/ezu471. Epub 2014 Dec 13.
6
Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices.用于手术植入的聚合物心脏瓣膜、基于导管的技术和心脏辅助设备。
Biomaterials. 2015 Jan;36:6-25. doi: 10.1016/j.biomaterials.2014.09.013.
7
Clinical experience with the freedom SOLO stentless aortic valve in 277 consecutive patients.
Ann Thorac Surg. 2014 Oct;98(4):1301-7. doi: 10.1016/j.athoracsur.2014.05.089. Epub 2014 Aug 20.
8
Tissue valve is the preferred option for patients aged 60 and older.对于60岁及以上的患者,组织瓣膜是首选选项。
Circulation. 2013 Sep 17;128(12):1365-71. doi: 10.1161/CIRCULATIONAHA.113.002584.
9
The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years.索林无支架心包瓣膜:10年临床及超声心动图表现
Int J Artif Organs. 2012 Jul;35(7):481-8. doi: 10.5301/ijao.5000103.
10
Nanocomposite biomaterial mimicking aortic heart valve leaflet mechanical behaviour.模拟主动脉心脏瓣膜小叶力学行为的纳米复合生物材料。
Proc Inst Mech Eng H. 2011 Jul;225(7):718-22. doi: 10.1177/0954411911399826.